Functional heartburn, nonerosive reflux disease, and reflux esophagitis are all distinct conditions--a debate: pro.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 17761122)

Published in Curr Treat Options Gastroenterol on August 01, 2007

Authors

Tomás Navarro-Rodriguez1, Ronnie Fass

Author Affiliations

1: Ronnie Fass, MD GI Section (1-111G-1), The Neuro-Enteric Clinical Research Group, Southern Arizona VA Health Care System, 3601 South 6th Avenue, Tucson, AZ 85723-0001, USA. Ronnie.fass@va.gov.

Articles by these authors

(truncated to the top 100)

Report of the Asia-Pacific consensus on the management of gastroesophageal reflux disease. J Gastroenterol Hepatol (2004) 2.86

Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin Gastroenterol Hepatol (2004) 2.65

Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults - update 2004. Can J Gastroenterol (2005) 2.36

Is proton pump inhibitor testing an effective approach to diagnose gastroesophageal reflux disease in patients with noncardiac chest pain?: a meta-analysis. Arch Intern Med (2005) 2.35

Asia-Pacific consensus on the management of gastroesophageal reflux disease: update. J Gastroenterol Hepatol (2008) 2.28

Effects of gastroesophageal reflux disease on sleep and outcomes. Clin Gastroenterol Hepatol (2009) 1.76

Upper GI tract findings in patients with heartburn in whom proton pump inhibitor treatment failed versus those not receiving antireflux treatment. Gastrointest Endosc (2010) 1.69

Relationship between rate of change in acid exposure along the esophagus and length of Barrett's epithelium. Am J Gastroenterol (2002) 1.56

Evaluation of symptom index in identifying gastroesophageal reflux disease-related noncardiac chest pain. J Clin Gastroenterol (2004) 1.52

Irritable bowel syndrome patients show enhanced modulation of visceral perception by auditory stress. Am J Gastroenterol (2003) 1.50

Bladder cancer presenting as lower-GI bleeding. Dig Dis Sci (2008) 1.47

Clinical predictors of Barrett's esophagus length. Gastrointest Endosc (2005) 1.45

Comparison of clinical characteristics of patients with gastroesophageal reflux disease who failed proton pump inhibitor therapy versus those who fully responded. J Neurogastroenterol Motil (2011) 1.32

The effect of life stress on symptoms of heartburn. Psychosom Med (2004) 1.28

Noncardiac chest pain: evaluation and treatment. Gastroenterol Clin North Am (2003) 1.26

Prevalence of upper gastrointestinal tract findings in patients with noncardiac chest pain versus those with gastroesophageal reflux disease (GERD)-related symptoms: results from a national endoscopic database. Am J Gastroenterol (2007) 1.22

The diagnosis of gastroesophageal reflux disease. Am J Med (2010) 1.17

Preoperative diagnostic workup before antireflux surgery: an evidence and experience-based consensus of the Esophageal Diagnostic Advisory Panel. J Am Coll Surg (2013) 1.16

Laparoscopic resection of a small bowel lipoma with incidental intussusception. JSLS (2011) 1.12

Increased expression and secretion of interleukin-6 in patients with Barrett's esophagus. Clin Cancer Res (2004) 1.10

Sleep deprivation is hyperalgesic in patients with gastroesophageal reflux disease. Gastroenterology (2007) 1.07

Pharmacological management of GERD: where does it stand now? Trends Pharmacol Sci (2011) 1.06

Is there a relationship between obstructive sleep apnea and gastroesophageal reflux disease? Clin Gastroenterol Hepatol (2004) 1.05

Management of gastroesophageal reflux disease that does not respond well to proton pump inhibitors. Curr Opin Gastroenterol (2010) 1.04

Nonerosive Reflux Disease (NERD) - An Update. J Neurogastroenterol Motil (2010) 1.04

Gastroesophageal reflux disease in noncardiac chest pain. Gastroenterol Clin North Am (2004) 1.04

Relationships between sleep quality and pH monitoring findings in persons with gastroesophageal reflux disease. J Clin Sleep Med (2007) 1.03

Gastroesophageal reflux disease (GERD) and irritable bowel syndrome (IBS)--is it one disease or an overlap of two disorders? Dig Dis Sci (2008) 0.99

A systematic review of the definitions, prevalence, and response to treatment of nocturnal gastroesophageal reflux disease. Clin Gastroenterol Hepatol (2008) 0.99

An algorithm for diagnosis and treatment of refractory GERD. Best Pract Res Clin Gastroenterol (2010) 0.98

Treatment of patients with diabetic gastroparesis. Gastroenterol Hepatol (N Y) (2010) 0.95

The pathophysiology of non-cardiac chest pain. J Gastroenterol Hepatol (2005) 0.95

Functional heartburn patients demonstrate traits of functional bowel disorder but lack a uniform increase of chemoreceptor sensitivity to acid. Am J Gastroenterol (2006) 0.95

The proton pump inhibitor (PPI) test in GERD: does it still have a role? J Clin Gastroenterol (2008) 0.93

Nonmedical therapeutic strategies for nonerosive reflux disease. J Clin Gastroenterol (2014) 0.93

Gastroesophageal reflux disease and sleep disturbances. J Gastroenterol (2012) 0.91

Comparison of esophageal acid exposure distribution along the esophagus among the different gastroesophageal reflux disease (GERD) groups. Am J Gastroenterol (2006) 0.91

Insights into gastroesophageal reflux disease-associated dyspeptic symptoms. Clin Gastroenterol Hepatol (2011) 0.90

Multiple myeloma presenting with a colonic obstruction and bony lesions: a clinical dilemma. J Clin Oncol (2008) 0.90

Perils of immunohistochemistry: variability in staining specificity of commercially available COX-2 antibodies on human colon tissue. Dig Dis Sci (2003) 0.89

Dexlansoprazole MR: a review. Ann Med (2011) 0.88

The role of proton pump inhibitors in gastro-oesophageal reflux disease. Drugs (2004) 0.88

Noncardiac chest pain: current treatment. Gastroenterol Hepatol (N Y) (2007) 0.87

Gastroesophageal reflux disease: presentation and assessment of a common, challenging disorder. Clin Cornerstone (2003) 0.86

Conscious awakenings are commonly associated with Acid reflux events in patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol (2010) 0.85

Treatment of esophageal motility disorders based on the chicago classification. Curr Treat Options Gastroenterol (2014) 0.84

Extraesophageal and atypical manifestations of GERD. J Gastroenterol Hepatol (2004) 0.84

The value of ambulatory 24 hr esophageal pH monitoring in clinical practice in patients who were referred with persistent gastroesophageal reflux disease (GERD)-related symptoms while on standard dose anti-reflux medications. Dig Dis Sci (2005) 0.84

Progression or regression of Barrett's esophagus--is it all in the eye of the beholder? Am J Gastroenterol (2003) 0.83

Power spectral analysis of the sleep electroencephalogram in heartburn patients with or without gastroesophageal reflux disease: a feasibility study. J Clin Gastroenterol (2010) 0.83

Gastroesophageal reflux disease and irritable bowel syndrome: a common overlap syndrome. Curr Gastroenterol Rep (2006) 0.83

The relationship between type 2 diabetes mellitus and failure to proton pump inhibitor treatment in gastroesophageal reflux disease. J Clin Gastroenterol (2012) 0.83

Attitudes and referral patterns of primary care physicians when evaluating subjects with noncardiac chest pain--a national survey. Dig Dis Sci (2005) 0.83

Pathogenesis of diarrhea in the adult: diagnostic challenges and life-threatening conditions. Eur J Gastroenterol Hepatol (2006) 0.83

Comparison of the different characteristics of sensed reflux events among different heartburn groups. J Clin Gastroenterol (2009) 0.82

Psychological distress is not associated with treatment failure in patients with gastroesophageal reflux disease. J Psychosom Res (2013) 0.82

Abnormal expression of biomarkers in incompletely ablated Barrett's esophagus. Ann Surg (2006) 0.82

Comparison of the degree of duodenogastroesophageal reflux and acid reflux between patients who failed to respond and those who were successfully treated with a proton pump inhibitor once daily. Am J Gastroenterol (2009) 0.82

Noncardiac chest pain. Clin Gastroenterol Hepatol (2006) 0.82

Gastro-oesophageal reflux disease: beyond proton pump inhibitor therapy. Drugs (2011) 0.81

Impact of esophageal acid exposure on the endoscopic reversal of Barrett's esophagus. Am J Gastroenterol (2002) 0.81

Physicians and patients measure different dimension on assessment for gastroesophageal reflux disease-related symptoms [corrected]. J Neurogastroenterol Motil (2011) 0.81

Ambulatory esophageal pH monitoring: new directions. Dig Dis (2006) 0.81

Reassessment of the principal characteristics of gastroesophageal reflux during the recumbent period using integrated actigraphy-acquired information. Am J Gastroenterol (2009) 0.81

Gastroesophageal reflux disease and sleep. Gastroenterol Clin North Am (2013) 0.80

Review: treatment of gastroesophageal reflux disease in the elderly. Am J Med (2010) 0.80

Usage of supplemental alternative medicine by community-based patients with gastroesophageal reflux disease (GERD). Dig Dis Sci (2002) 0.80

Functional heartburn. Curr Treat Options Gastroenterol (2005) 0.79

New therapies for non-cardiac chest pain. Curr Gastroenterol Rep (2014) 0.79

A predictive model for length of Barrett's esophagus with hiatal hernia length and duration of esophageal acid exposure. Gastrointest Endosc (2003) 0.79

GERD: are functional heartburn and functional dyspepsia one disorder? Nat Rev Gastroenterol Hepatol (2010) 0.79

Impaired sleep quality in Crohn's disease depends on disease activity. Dig Dis Sci (2013) 0.78

Current perspectives on the diagnosis and treatment of functional esophageal disorders. Curr Gastroenterol Rep (2003) 0.78

Effect of body weight and esophageal damage on the severity of gastroesophageal reflux symptoms. Mexican GERD working group. Arch Med Res (2009) 0.78

The relationship between the prevalence of nighttime gastroesophageal reflux disease and disease severity. Dig Dis Sci (2009) 0.78

Colon cancer presenting as upper-GI bleeding. Gastrointest Endosc (2006) 0.78

Advancements in the analysis of esophageal pH monitoring in GERD. Nat Rev Gastroenterol Hepatol (2011) 0.77

The role of mucin in GERD and its complications. Nat Rev Gastroenterol Hepatol (2011) 0.77

Assessment of relationship between acid reflux and heartburn using receiver operating characteristic curves. Gastroenterol Clin North Am (2002) 0.77

The Effect of Ramelteon on Heartburn Symptoms of Patients With Gastroesophageal Reflux Disease and Chronic Insomnia: A Pilot Study. J Clin Gastroenterol (2016) 0.77

Gastroesophageal Reflux Disease: Cross-Sectional Study Demonstrating Rising Prevalence in a Chinese Population. J Clin Gastroenterol (2016) 0.77

Noncardiac chest pain: the role of the cardiologist--a national survey. J Clin Gastroenterol (2005) 0.76

Irritable bowel syndrome: a global view. J Gastroenterol Hepatol (2003) 0.76

Oesophageal sensation in response to high PCO(2) and acidic solutions in nonerosive reflux disease. Eur J Clin Invest (2011) 0.75

Identifying Minimal Changes in Nonerosive Reflux Disease: Is the Pay Worth the Labor? J Clin Gastroenterol (2016) 0.75

Symptom indexes in refractory gastroesophageal reflux disease: overrated or misunderstood? Clin Gastroenterol Hepatol (2011) 0.75

The Proton Pump Inhibitor Non-Responder: A Clinical Conundrum. Clin Transl Gastroenterol (2015) 0.75

Healing erosive esophagitis with a proton pump inhibitor: the more the merrier? Am J Gastroenterol (2012) 0.75

Discrepancies between upper GI symptoms described by those who have them and their identification by conventional medical terminology: a survey of sufferers in four countries. Eur J Gastroenterol Hepatol (2016) 0.75

Nutcracker esophagus--a nut hard to swallow. J Clin Gastroenterol (2006) 0.75

The Overlap Between GERD and Functional Bowel Disorders - When East Meets Rome. J Neurogastroenterol Motil (2010) 0.75

Intravenous glucagon in food impaction--use it or lose it? Dysphagia (2004) 0.75

Functional gastrointestinal disorders: Venlafaxine is a potential therapy for functional chest pain. Nat Rev Gastroenterol Hepatol (2011) 0.75

GERD: Surgery or medical therapy for patients with GERD? Nat Rev Gastroenterol Hepatol (2013) 0.75

Distribution of Esophageal Motor Disorders in Diabetic Patients With Dysphagia. J Clin Gastroenterol (2017) 0.75

Nocturnal Gastroesophageal Reflux Disease (GERD) and Sleep: An Important Relationship That Is Commonly Overlooked. J Clin Gastroenterol (2020) 0.75

Noncardiac Chest Pain. Curr Treat Options Gastroenterol (2004) 0.75

Development of a Preliminary Question Prompt List as a Communication Tool for Adults With Achalasia: A Modified Delphi Study. J Clin Gastroenterol (2022) 0.75

Noncardiac chest pain: diagnosis and management. Curr Opin Gastroenterol (2017) 0.75

Doctor to doctor: Med World News (1993) 0.75